| Company/Division name | Engineered BioPharmaceuticals |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 34 |
| Year reshoring announced: | 2023 |
| Capital investment ($): | 6.1 |
| City reshored to: | Danville |
| State(s) reshored to: | VA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | oral pharmaceutical dosing,dry powder |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Skilled workforce availability/training, Under-utilized capacity, $150,000 grant from the Commonwealth’s Opportunity |
